198 related articles for article (PubMed ID: 33757212)
1. Data-driven biomarker analysis using computational omics approaches to assess neurodegenerative disease progression.
Krokidis MG; Exarchos TP; Vlamos P
Math Biosci Eng; 2021 Feb; 18(2):1813-1832. PubMed ID: 33757212
[TBL] [Abstract][Full Text] [Related]
2. From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology.
Toader C; Dobrin N; Brehar FM; Popa C; Covache-Busuioc RA; Glavan LA; Costin HP; Bratu BG; Corlatescu AD; Popa AA; Ciurea AV
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003309
[TBL] [Abstract][Full Text] [Related]
3. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
[TBL] [Abstract][Full Text] [Related]
4. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
Clark LF; Kodadek T
ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
[TBL] [Abstract][Full Text] [Related]
5. Biosensor approaches on the diagnosis of neurodegenerative diseases: Sensing the past to the future.
Karaboğa MNS; Sezgintürk MK
J Pharm Biomed Anal; 2022 Feb; 209():114479. PubMed ID: 34861607
[TBL] [Abstract][Full Text] [Related]
6. Blood biomarker-based classification study for neurodegenerative diseases.
Kelly J; Moyeed R; Carroll C; Luo S; Li X
Sci Rep; 2023 Oct; 13(1):17191. PubMed ID: 37821485
[TBL] [Abstract][Full Text] [Related]
7. Mass spectrometry: A platform for biomarker discovery and validation for Alzheimer's and Parkinson's diseases.
Cilento EM; Jin L; Stewart T; Shi M; Sheng L; Zhang J
J Neurochem; 2019 Nov; 151(4):397-416. PubMed ID: 30474862
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers of neurodegenerative disorders: how good are they?
Rachakonda V; Pan TH; LE WD
Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
[TBL] [Abstract][Full Text] [Related]
9. A review on omics-based biomarkers discovery for Alzheimer's disease from the bioinformatics perspectives: Statistical approach vs machine learning approach.
Tan MS; Cheah PL; Chin AV; Looi LM; Chang SW
Comput Biol Med; 2021 Dec; 139():104947. PubMed ID: 34678481
[TBL] [Abstract][Full Text] [Related]
10. Circulating miRNAs as biomarkers for neurodegenerative disorders.
Grasso M; Piscopo P; Confaloni A; Denti MA
Molecules; 2014 May; 19(5):6891-910. PubMed ID: 24858274
[TBL] [Abstract][Full Text] [Related]
11. Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases.
La Cognata V; Morello G; Cavallaro S
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062930
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers for the early detection of Parkinson's and Alzheimer's disease.
Berg D
Neurodegener Dis; 2008; 5(3-4):133-6. PubMed ID: 18322370
[TBL] [Abstract][Full Text] [Related]
13. Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases.
Htike TT; Mishra S; Kumar S; Padmanabhan P; Gulyás B
Mol Neurobiol; 2019 Mar; 56(3):2256-2277. PubMed ID: 30008073
[TBL] [Abstract][Full Text] [Related]
14. Artificial intelligence-coupled plasmonic infrared sensor for detection of structural protein biomarkers in neurodegenerative diseases.
Kavungal D; Magalhães P; Kumar ST; Kolla R; Lashuel HA; Altug H
Sci Adv; 2023 Jul; 9(28):eadg9644. PubMed ID: 37436975
[TBL] [Abstract][Full Text] [Related]
15. Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.
Noelker C; Hampel H; Dodel R
Mol Diagn Ther; 2011 Apr; 15(2):83-102. PubMed ID: 21623645
[TBL] [Abstract][Full Text] [Related]
16. Comparing Alzheimer's and Parkinson's diseases networks using graph communities structure.
Calderone A; Formenti M; Aprea F; Papa M; Alberghina L; Colangelo AM; Bertolazzi P
BMC Syst Biol; 2016 Mar; 10():25. PubMed ID: 26935435
[TBL] [Abstract][Full Text] [Related]
17. Proteomics for Target Identification in Psychiatric and Neurodegenerative Disorders.
Antunes ASLM; de Almeida V; Crunfli F; Carregari VC; Martins-de-Souza D
Adv Exp Med Biol; 2021; 1286():251-264. PubMed ID: 33725358
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome-based biomarker prediction for Parkinson's disease using genome-scale metabolic modeling.
Abdik E; Çakır T
Sci Rep; 2024 Jan; 14(1):585. PubMed ID: 38182712
[TBL] [Abstract][Full Text] [Related]
19. [Treatment-Quo vadis neurodegeneration?].
Vöglein J; Levin J; Höglinger G
Nervenarzt; 2023 Oct; 94(10):904-912. PubMed ID: 37801166
[TBL] [Abstract][Full Text] [Related]
20. Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease.
Bach JP; Gold M; Mengel D; Hattesohl A; Lubbe D; Schmid S; Tackenberg B; Rieke J; Maddula S; Baumbach JI; Nell C; Boeselt T; Michelis J; Alferink J; Heneka M; Oertel W; Jessen F; Janciauskiene S; Vogelmeier C; Dodel R; Koczulla AR
PLoS One; 2015; 10(7):e0132227. PubMed ID: 26168044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
